Michael Müller
- Endobronchial identification of persistent peripheral bronchopleural fistula with digital chest tube monitoring followed by treatment with endobronchial one-way valve implantationBy Irene Firlinger, Elisabeth Stubenberger, Michael Müller, Otto Burghuber and Arschang ValipourIrene Firlinger1Respiratory and Critical Care Medicine, Otto Wagner Hospital, Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Vienna, AustriaElisabeth Stubenberger2Thoracic Surgery, Otto Wagner Hospital, Vienna, AustriaMichael Müller2Thoracic Surgery, Otto Wagner Hospital, Vienna, AustriaOtto Burghuber1Respiratory and Critical Care Medicine, Otto Wagner Hospital, Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Vienna, AustriaArschang Valipour1Respiratory and Critical Care Medicine, Otto Wagner Hospital, Ludwig-Boltzmann-Institute for COPD and Respiratory Epidemiology, Vienna, Austria
- Anemia in chronic respiratory failureBy Florian Kollert, Carolin Müller, Andrea Tippelt, Rudolf A. Joerres, Dominik Heidinger, Corina Probst, Michael Pfeifer and Stephan BudweiserFlorian KollertCarolin Müller2Centre for Pneumology, Donaustauf Hospital, Donaustauf, GermanyAndrea Tippelt2Centre for Pneumology, Donaustauf Hospital, Donaustauf, GermanyRudolf A. Joerres3Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, Ludwigs-Maximillians-Universität, München, GermanyDominik Heidinger2Centre for Pneumology, Donaustauf Hospital, Donaustauf, GermanyCorina Probst4Department of Pneumology, University of Freiburg, Freiburg, GermanyMichael Pfeifer
- Short term glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: “REDUCE*”, a non-inferiority multicenter trial. (*Reduction in the Use of Corticosteroids in Exacerbated COPD; ISRCTN19646069)By Jörg D. Leuppi, Philipp Schütz, Roland Bingisser, Matthias Briel, Tilman Drescher, Ursula Dürring, Christoph Henzen, Yolanda Leibbrandt, Sabrina Maier, David Miedinger, Beat Müller, Andreas Scherr, Christian Schindler, Rolf Stöckli, Sebastian Viatte, Christophe von Garnier, Michael Tamm and Jonas RutishauserJörg D. Leuppi1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandPhilipp Schütz2Clinic of Internal Medicine, Canton Hospital, Aarau, SwitzerlandRoland Bingisser3Interdisciplinary Emergency Department, University Hospital, Basel, SwitzerlandMatthias Briel4Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital, Basel, SwitzerlandTilman Drescher1Clinic of Internal Medicine, University Hospital, Basel, Switzerland5Clinic for Endocrinology, Diabetology, and Clinical Nutrition, University Hospital, Basel, SwitzerlandUrsula Dürring5Clinic for Endocrinology, Diabetology, and Clinical Nutrition, University Hospital, Basel, SwitzerlandChristoph Henzen6Department of Internal Medicine, Canton Hospital, Luzern, SwitzerlandYolanda Leibbrandt7Clinic of Internal Medicine, Hospital Center, Biel-Bienne, SwitzerlandSabrina Maier1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandDavid Miedinger1Clinic of Internal Medicine, University Hospital, Basel, SwitzerlandBeat Müller2Clinic of Internal Medicine, Canton Hospital, Aarau, SwitzerlandAndreas Scherr1Clinic of Internal Medicine, University Hospital, Basel, Switzerland8Clinic for Pneumology, University Hospital, Basel, SwitzerlandChristian Schindler9Swiss Tropical and Public Health Institute, University of Basel, SwitzerlandRolf Stöckli5Clinic for Endocrinology, Diabetology, and Clinical Nutrition, University Hospital, Basel, SwitzerlandSebastian Viatte7Clinic of Internal Medicine, Hospital Center, Biel-Bienne, SwitzerlandChristophe von Garnier10Clinic of Pneumology, University Hospital, Bern, SwitzerlandMichael Tamm8Clinic for Pneumology, University Hospital, Basel, SwitzerlandJonas Rutishauser7Clinic of Internal Medicine, Hospital Center, Biel-Bienne, Switzerland
- Is the bacterium Tropheryma whipplei cause of the disease in a subgroup of patients with presumed sarcoidosis?By Emina Dulic-Lakovic, Marianne Hubner, Christian Müller, Wolfgang Pokieser, Melisa Dulic, Sabine Publig, Meinhard Kneussl and Michael GschwantlerEmina Dulic-Lakovic1Department of Internal Medicine IV, Wilhelminenspital, Vienna, AustriaMarianne Hubner2Department of Internal Medicine II, Wilhelminenspital, Vienna, AustriaChristian Müller3Department of Internal Medicine III, AKH & Medical University Vienna, Vienna, AustriaWolfgang Pokieser4Institute of Pathology and Bacteriology, Wilhelminenspital, Vienna, AustriaMelisa Dulic1Department of Internal Medicine IV, Wilhelminenspital, Vienna, AustriaSabine Publig2Department of Internal Medicine II, Wilhelminenspital, Vienna, AustriaMeinhard Kneussl2Department of Internal Medicine II, Wilhelminenspital, Vienna, AustriaMichael Gschwantler1Department of Internal Medicine IV, Wilhelminenspital, Vienna, Austria
- Pancreatic stone protein predicts positive sputum bacteriology in exacerbations of COPDBy Andreas Scherr, Rolf Graf, Martha Bain, Miriam Christ-Crain, Beat Müller, Frederic Lajaunias, Michael Tamm and Daiana StolzAndreas Scherr1Clinic of Pneumology, University Hospital, Basel, SwitzerlandRolf Graf2Pancreatitis Research Laboratory, University Hospital, Zürich, SwitzerlandMartha Bain2Pancreatitis Research Laboratory, University Hospital, Zürich, SwitzerlandMiriam Christ-Crain3Clinic of Endocrinology, University Hospital, Basel, SwitzerlandBeat Müller4Internal Medicine, Hospital of Aarau, Argovia, SwitzerlandFrederic Lajaunias5LASCCO SA Geneva, LASCCO, Geneva, SwitzerlandMichael Tamm1Clinic of Pneumology, University Hospital, Basel, SwitzerlandDaiana Stolz1Clinic of Pneumology, University Hospital, Basel, Switzerland
- Adenovirus-specific immunoglobulin G maturation in acute exacerbations of COPDBy Lucas Boeck, Mikael Gencay, Michael Roth, Hans Hirsch, Mirjam Christ-Crain, Beat Müller, Michael Tamm and Daiana StolzLucas Boeck1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandMikael Gencay1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandMichael Roth1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandHans Hirsch2Transplantation and Clinical Virology, Department of Biomedicine, University Basel, Basel, SwitzerlandMirjam Christ-Crain3Department of Endocrinology, Diabetes and Metabolism, University Hospital Basel, Basel, SwitzerlandBeat Müller4Medical University Department, Kantonsspital Aarau, Aarau, SwitzerlandMichael Tamm1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, SwitzerlandDaiana Stolz1Clinic of Pulmonary Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland
- Recurrent respiratory papillomatosis - rapid response to systemic bevacizumabBy Christoph Schliemann, Christoph Biermann, Andreas Hilbis, Thorsten Kessler, Joachim Schmidt, Karsten Wiebe, Klaus-Michael Müller, Thomas K. Hoffmann, Claudius Werner, Andreas H. Groll, Christina Kessler, Rainer Wiewrodt, Claudia Rudack, Berdel Wolfgang and Michael MohrChristoph Schliemann1Medicine A, Hematology/Oncology/Pneumology, University Hospital Muenster, Muenster, GermanyChristoph Biermann1Medicine A, Hematology/Oncology/Pneumology, University Hospital Muenster, Muenster, GermanyAndreas Hilbis1Medicine A, Hematology/Oncology/Pneumology, University Hospital Muenster, Muenster, GermanyThorsten Kessler1Medicine A, Hematology/Oncology/Pneumology, University Hospital Muenster, Muenster, GermanyJoachim Schmidt2Thoracic Surgery, University Hospital Muenster, Muenster, GermanyKarsten Wiebe2Thoracic Surgery, University Hospital Muenster, Muenster, GermanyKlaus-Michael Müller3Pathology, University Hospital Muenster, Muenster, GermanyThomas K. Hoffmann4Pediatrics, University Hospital Muenster, Muenster, GermanyClaudius Werner5Otorhinolaryngology, University Hospital Ulm, Ulm, GermanyAndreas H. Groll7Pediatric Hematology/Oncology, University Hospital Muenster, Muenster, GermanyChristina Kessler5Otorhinolaryngology, University Hospital Ulm, Ulm, GermanyRainer Wiewrodt5Otorhinolaryngology, University Hospital Ulm, Ulm, GermanyClaudia Rudack6Otolaryngology/Head and Neck Cancer, University Hospital Muenster, Muenster, GermanyBerdel Wolfgang1Medicine A, Hematology/Oncology/Pneumology, University Hospital Muenster, Muenster, GermanyMichael Mohr1Medicine A, Hematology/Oncology/Pneumology, University Hospital Muenster, Muenster, Germany
- Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancerBy Michael Thomas, Jürgen Fischer, Stefan Andreas, Cornelius Kortsik, Christian Grah, Monika Serke, Michael von Eiff, Christian Witt, Jens Kollmeier, Ernst Müller, Michael Schenk, Michael Schröder, Matthias Villalobos, Niels Reinmuth, Roland Penzel, Philipp Schnabel, Thomas Acker, Alexander Reuss and Martin WolfArticle | Published in 2015 in European Respiratory JournalMichael Thomas1Dept of Thoracic Oncology, Thoraxklinik, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyJürgen Fischer2Med. Clinic II, Oncology, Klinik Löwenstein, Löwenstein, GermanyStefan Andreas3Lungenfachklinik Immenhausen, Immenhausen, Germany4Dept of Pneumology, Universitätsmedizin Göttingen, Göttingen, GermanyCornelius Kortsik5Pneumology, Katholisches Klinikum Mainz, Mainz, GermanyChristian Grah6Pneumology and Lung Cancer Center, Gemeinschaftskrankenhaus Havelhöhe, Berlin, GermanyMonika Serke7Pneumology/Oncology, Lungenklinik Hemer, Hemer, GermanyMichael von Eiff8Malteser Krankenhaus St Hildegardis, Internal Medicine, Cologne, GermanyChristian Witt9Dept of Pneumological Oncology, Charité-Universitätsmedizin Berlin, Berlin, GermanyJens Kollmeier10Lungenklinik Heckershorn, HELIOS Klinikum Emil von Behring, Berlin, GermanyErnst Müller11Forschungszentrum Borstel, Medizinische Klinik, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, GermanyMichael Schenk12Krankenhaus Barmherzige Brüder Regensburg, Clinic for Oncology and Hematology, Regensburg, GermanyMichael Schröder13Hematology/Oncology, HELIOS St Johannes Klinik, Duisburg, GermanyMatthias Villalobos1Dept of Thoracic Oncology, Thoraxklinik, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyNiels Reinmuth1Dept of Thoracic Oncology, Thoraxklinik, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany14Lungenclinic Großhansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Großhansdorf, GermanyRoland Penzel15Dept of Pathology, University of Heidelberg, Heidelberg, GermanyPhilipp Schnabel15Dept of Pathology, University of Heidelberg, Heidelberg, GermanyThomas Acker16Coordinating Center for Clinical Trials, University of Marburg, Marburg, GermanyAlexander Reuss16Coordinating Center for Clinical Trials, University of Marburg, Marburg, GermanyMartin Wolf17Med. Clinic IV, Hematology/Oncology, Klinikum Kassel, Kassel, Germany
- Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancerBy Michael Thomas, Jürgen Fischer, Stefan Andreas, Cornelius Kortsik, Christian Grah, Monika Serke, Michael von Eiff, Christian Witt, Jens Kollmeier, Ernst Müller, Michael Schenk, Michael Schröder, Matthias Villalobos, Niels Reinmuth, Roland Penzel, Philipp Schnabel, Thomas Acker, Alexander Reuss and Martin WolfMichael Thomas1Dept of Thoracic Oncology, Thoraxklinik, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyJürgen Fischer2Med. Clinic II, Oncology, Klinik Löwenstein, Löwenstein, GermanyStefan Andreas3Lungenfachklinik Immenhausen, Immenhausen, Germany4Dept of Pneumology, Universitätsmedizin Göttingen, Göttingen, GermanyCornelius Kortsik5Pneumology, Katholisches Klinikum Mainz, Mainz, GermanyChristian Grah6Pneumology and Lung Cancer Center, Gemeinschaftskrankenhaus Havelhöhe, Berlin, GermanyMonika Serke7Pneumology/Oncology, Lungenklinik Hemer, Hemer, GermanyMichael von Eiff8Malteser Krankenhaus St Hildegardis, Internal Medicine, Cologne, GermanyChristian Witt9Dept of Pneumological Oncology, Charité-Universitätsmedizin Berlin, Berlin, GermanyJens Kollmeier10Lungenklinik Heckershorn, HELIOS Klinikum Emil von Behring, Berlin, GermanyErnst Müller11Forschungszentrum Borstel, Medizinische Klinik, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Borstel, GermanyMichael Schenk12Krankenhaus Barmherzige Brüder Regensburg, Clinic for Oncology and Hematology, Regensburg, GermanyMichael Schröder13Hematology/Oncology, HELIOS St Johannes Klinik, Duisburg, GermanyMatthias Villalobos1Dept of Thoracic Oncology, Thoraxklinik, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, GermanyNiels Reinmuth1Dept of Thoracic Oncology, Thoraxklinik, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany14Lungenclinic Großhansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Großhansdorf, GermanyRoland Penzel15Dept of Pathology, University of Heidelberg, Heidelberg, GermanyPhilipp Schnabel15Dept of Pathology, University of Heidelberg, Heidelberg, GermanyThomas Acker16Coordinating Center for Clinical Trials, University of Marburg, Marburg, GermanyAlexander Reuss16Coordinating Center for Clinical Trials, University of Marburg, Marburg, GermanyMartin Wolf17Med. Clinic IV, Hematology/Oncology, Klinikum Kassel, Kassel, Germany
- Isolation of stenotrophomonas maltophilia in lung transplant recipients: effects of treatment on prevalence and outcomeBy Patrick Hofmann, Michael Hombach, Macé Schuurmans, Urs Bürgi, Bruno Isenring, Nicolas Müller, Malcolm Kohler, Christian Benden and Lars HuberPatrick Hofmann1Division of Pulmonology, University Hospital Zurich, Zurich, SwitzerlandMichael Hombach2Institute of Medical Microbiology, University Hospital Zurich, Zurich, SwitzerlandMacé Schuurmans1Division of Pulmonology, University Hospital Zurich, Zurich, SwitzerlandUrs Bürgi1Division of Pulmonology, University Hospital Zurich, Zurich, SwitzerlandBruno Isenring1Division of Pulmonology, University Hospital Zurich, Zurich, SwitzerlandNicolas Müller3Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, SwitzerlandMalcolm Kohler1Division of Pulmonology, University Hospital Zurich, Zurich, SwitzerlandChristian Benden1Division of Pulmonology, University Hospital Zurich, Zurich, SwitzerlandLars Huber1Division of Pulmonology, University Hospital Zurich, Zurich, Switzerland
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, and a companion volume of self-assessment questions is available. In 2015, the first ERS Practical Handbook, on Noninvasive Ventilation, was added to the series